Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-3,012
Closed -$265K – 606
2023
Q4
$265K Sell
3,012
-38
-1% -$3.17K 0.01% 423
2023
Q3
$258K Buy
3,050
+153
+5% +$13.8K 0.01% 396
2023
Q2
$286K Sell
2,897
-71
-2% -$6.68K 0.01% 393
2023
Q1
$285K Buy
2,968
+192
+7% +$17.8K 0.01% 426
2022
Q4
$252K Buy
+2,776
New +$236K 0.01% 473
2020
Q3
– Sell
-3
Closed – – 340
2020
Q2
$0 Sell
3
-75
-96% -$4.63K ﹤0.01% 930
2020
Q1
$4K Buy
+78
New +$5.23K ﹤0.01% 503

Other funds holding DOX

Balentine LLC's DOX Position: Q1 2024 in Review

Balentine LLC sold out of Amdocs (DOX) in Q1 2024, closing a stake of 3,012 shares — an estimated $265K sold.

Balentine LLC first reported a position in DOX in Q1 2020 and held it in 7 quarters. The position peaked at $286K in Q2 2023. 511 funds tracked by Wall St. Rank hold DOX as of Q1 2024.

  • Balentine LLC reported no remaining Amdocs position as of Q1 2024 after selling out during the quarter.
  • Balentine LLC sold 3,012 Amdocs shares in Q1 2024, an estimated $265K.
  • Balentine LLC first reported a position in Amdocs in Q1 2020 and held it in 7 quarters.
  • Balentine LLC's Amdocs position peaked at $286K in Q2 2023.
  • 511 funds tracked by Wall St. Rank held Amdocs as of Q1 2024.

Based on Balentine LLC's 13F filing for Q1 2024, filed 15 May 2024.